DEA makes tramadol a Schedule IV drug
The US Drug Enforcement Administration has published a Final Rule that switches tramadol from a legend drug to a Schedule IV controlled substance, effective August 18, 2014.
As of the effective date, all drug manufacturers will be required to print the designation “C-IV” on every bottle of medication and it will be unlawful for commercial containers of tramadol to be distributed without that designation. In addition, all DEA registrants will be required to take an inventory of all tramadol stock.
For additional information, read the Final Rule.
